Login / Signup

Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment.

Mona M A Abdel-MottalebLorenza BoiMarina BarraJulie ColinLuisa BerniArnaud BéduneauBrice MoulariYann Pellequer
Published in: Materials (Basel, Switzerland) (2023)
Lipoproteins are natural nanostructures responsible for the transport of cholesterol and other lipids in the blood. They are characterized by having a lipophilic core surrounded by an amphiphilic shell composed of phospholipids, cholesterol and one or more apolipoproteins. Being endogenous carriers makes them suitable for drug delivery purposes. Here, we investigate the effect of lipoproteins' intricate composition on the entrapment efficiency of a model drug "Cyclosporine A" into the different types of lipoproteins, namely, HDL, LDL and VLDL. It was observed that the protein content of the lipoproteins had the highest effect on the entrapment of the drug with a correlation coefficient of 0.80, 0.81 and 0.96 for HDL, LDL and VLDL respectively. This was even confirmed by the effect of plasma on the association rate of lipoproteins and the drug. The second effective factor is the cholesterol concentration, while triglycerides and phospholipids had a negligible effect.
Keyphrases
  • low density lipoprotein
  • drug delivery
  • adverse drug
  • cancer therapy
  • magnetic resonance
  • small molecule
  • binding protein
  • drug release
  • protein protein
  • contrast enhanced